CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 54 filers reported holding CTI BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $22,186,000 | +18.0% | 7,520,600 | 0.0% | 0.24% | +28.4% |
Q2 2021 | $18,802,000 | -14.1% | 7,520,600 | 0.0% | 0.19% | -7.3% |
Q1 2021 | $21,885,000 | -28.6% | 7,520,600 | -21.0% | 0.20% | -23.5% |
Q4 2020 | $30,656,000 | +49.8% | 9,520,600 | 0.0% | 0.27% | +4.3% |
Q3 2020 | $20,469,000 | +85.3% | 9,520,600 | 0.0% | 0.26% | +65.8% |
Q2 2020 | $11,044,000 | +26.1% | 9,520,600 | 0.0% | 0.16% | +5.4% |
Q1 2020 | $8,759,000 | +10.9% | 9,520,600 | +90.4% | 0.15% | +30.1% |
Q4 2019 | $7,900,000 | +88.8% | 5,000,000 | 0.0% | 0.11% | +43.0% |
Q3 2019 | $4,185,000 | -2.6% | 5,000,000 | 0.0% | 0.08% | +17.9% |
Q2 2019 | $4,297,000 | -11.4% | 5,000,000 | 0.0% | 0.07% | -10.7% |
Q1 2019 | $4,851,000 | +32.3% | 5,000,000 | 0.0% | 0.08% | +10.3% |
Q4 2018 | $3,668,000 | -66.0% | 5,000,000 | 0.0% | 0.07% | -47.7% |
Q3 2018 | $10,800,000 | -56.6% | 5,000,000 | 0.0% | 0.13% | -56.2% |
Q2 2018 | $24,900,000 | +27.7% | 5,000,000 | 0.0% | 0.30% | +22.7% |
Q1 2018 | $19,500,000 | +45.5% | 5,000,000 | 0.0% | 0.24% | +43.2% |
Q4 2017 | $13,400,000 | -16.0% | 5,000,000 | 0.0% | 0.17% | +11.2% |
Q3 2017 | $15,950,000 | -3.6% | 5,000,000 | 0.0% | 0.15% | -12.1% |
Q2 2017 | $16,550,000 | – | 5,000,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|